FAQ

Credelio is a monthly oral treatment for cats using lotilaner, while Bravecto is known for longer-lasting flea and tick protection with less frequent dosing.

Credelio is a vet-recommended oral flea treatment for cats, providing monthly protection against fleas and black-legged ticks with proven efficacy and safety.

Bravecto and Credelio are both oral flea and tick preventatives for pets, but Credelio for cats contains lotilaner and provides monthly protection, while Bravecto contains fluralaner and typically provides longer-lasting coverage.

Credelio for cats is a highly vet-recommended, FDA-approved oral flea and tick treatment known for its effectiveness and safety.

Bravecto and Credelio differ primarily in their dosing frequency and duration of action: Bravecto protects cats for up to 12 weeks with a single dose, while Credelio is administered monthly. Both contain isoxazoline ingredients and target fleas and ticks, but use different active substances.

Credelio for cats is a vet-recommended, FDA-approved oral flea treatment that effectively controls fleas and black-legged ticks for one month with one dose.

Cats with a history of seizures or neurological disorders should avoid flea treatments containing isoxazolines, such as Credelio, due to potential neurological side effects.

Yes, Credelio is FDA-approved for use on cats and kittens to treat and prevent fleas and control black-legged ticks.

Yes, Credelio is generally safe for cats when used as directed, with mild side effects and a good safety profile in healthy cats 8 weeks or older and weighing at least 2 pounds.

Credelio for cats, containing the active ingredient lotilaner, is considered a safe and FDA-approved monthly oral flea treatment for cats over 8 weeks old and weighing at least 2 pounds.